Development of Glatopa® (Glatiramer Acetate): The First FDA-Approved Generic Disease-Modifying Therapy for Relapsing Forms of Multiple Sclerosis

The multiple sclerosis (MS) treatment landscape in the United States has changed dramatically over the past decade. While many disease-modifying therapies (DMTs) have been approved by the US Food and Drug Administration (FDA) for the treatment of relapsing forms of MS, DMT costs continue to rise. Th...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Pharm Pract
Main Authors: Bell, Christine, Anderson, James, Ganguly, Tanmoy, Prescott, James, Capila, Ishan, Lansing, Jonathan C., Sachleben, Richard, Iyer, Mani, Fier, Ian, Roach, James, Storey, Kristina, Miller, Paul, Hall, Steven, Kantor, Daniel, Greenberg, Benjamin M., Nair, Kavita, Glajch, Joseph
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2017
Teme:
Review Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144347/
https://ncbi.nlm.nih.gov/pubmed/28847230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0897190017725984
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki